Article info

Download PDFPDF
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition

Authors

  1. Address correspondence and reprint requests to Karen H. Lu, MD, Department of Gynecologic Oncology and Reproductive Medicine, 1155 Hermann Pressler Dr, Unit 1362 Houston, TX 77030. E-mail: khlu@mdanderson.org.

Citation

Ring KL, Yates MS, Schmandt R, et al
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition

Publication history

  • Received October 14, 2016
  • First published June 1, 2017.
Online issue publication 
June 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.